MURIEL BOWSER
MAYOR
October 23, 2023
The Honorable Phil Mendelson
Chairman
Council of the District of Columbia
1350 Pennsylvania Avenue, NW, Suite 504
Washington, DC 20004-3001
Dear Chairman Mendelson:
As required by the Consolidated Appropriations Act, 202 , approved September 30, 202
( ), I am submitting for consideration by the Council of the District of Columbia the
enclosed FY 202 Grant Budget Modifications.
As always, my staff is available to discuss any questions you may have regarding the proposed
budget modifications. In order to facilitate a response to any questions regarding the
modifications, please have your staff contact
, at (202)
Thank you for your assistance in this matter.
Sincerely,
Muriel Bowser
Mayor of the District of Columbia
Enclosure
cc: Nyasha Smith, Secretary to the Council of the District of Columbia
Fitzroy Lee, Interim Chief Financial Officer
Angell Jacobs, Deputy Chief Financial Officer and Chief of Staff, Office of the Chief
Financial Officer
Eric M. Cannady, Deputy Chief Financial Officer, Office of Budget and Planning
MURIEL BOWSER
MAYOR
October 23, 2023
The Honorable Phil Mendelson
Chairman
Council of the District of Columbia
1350 Pennsylvania Avenue, NW, Suite 504
Washington, DC 20004-3001
Dear Chairman Mendelson:
As required by the Consolidated Appropriations Act, 202 , approved September 30, 202
( ), I am submitting for consideration by the Council of the District of Columbia the
enclosed FY 202 Grant Budget Modifications.
As always, my staff is available to discuss any questions you may have regarding the proposed
budget modifications. In order to facilitate a response to any questions regarding the
modifications, please have your staff contact
, at (202)
Thank you for your assistance in this matter.
Sincerely,
Muriel Bowser
Mayor of the District of Columbia
Enclosure
cc: Nyasha Smith, Secretary to the Council of the District of Columbia
Fitzroy Lee, Interim Chief Financial Officer
Angell Jacobs, Deputy Chief Financial Officer and Chief of Staff, Office of the Chief
Financial Officer
Eric M. Cannady, Deputy Chief Financial Officer, Office of Budget and Planning
39th Passive
COUNCIL OF THE DISTRICT OF COLUMBIA
FY 2023 GRANT BUDGET MODIFICATIONS AS OF OCTOBER 17, 2023
The following are FY 2023 Private Grant Budget Modifications:
Grant Reason for Budget FTE COVID
Agency Type Grant Name Request Amount Request -Related
Juntas Adelante: A
peer-coaching
Department of intervention to promote
Health Private chemoprophylaxis Establishment $26,090.00 0.0 No
District of Columbia
Department of Center for AIDS
Health Private Research (DC CFAR) Establishment $9,047.00 0.0 No
Integrating
Intersectionality
Department of Science to Engage
Health Private Intersectionally Establishment $14,631.00 0.0 No
DIFS Journal Budget Entry (OPERATING BUDGET ONLY)
Government of the District of Columbia Originating Agency Code and Name: HC0 Department of Health DATE
10/12/23
DOCUMENT INFORMATION
Fiscal Year: 2023 Agency Director: Dr. Ayanna Bennett Budget Document Amount: $26,090.00
Period: For Agency CFO: Adreana Deane
Effective Date: Associate CFO: Delcia Moore
Approval Required for the Following (Check all that apply): Approval Level:
Shift Between Agencies/Projects Shift Between Responsibility Centers/Programs Agency X DC Council
Shift Between Control Centers/Activities Shift Within Responsibility Centers/Programs OBP
CURRENT BUDGET REVISED BUDGET
FUND AGENCY PROGRAM COST CENTER ACCOUNT PROJECT AWARD TASK SUB-TASK EXPENDITURE TYPE AMT OF DECREASE AMT OF INCREASE
AUTHORITY AUTHORITY
4040002 HC0 700037 70078 7011001 202297 4000135 10 10.01 CONTINUING FULL TIME 0.00 22,620.03 22,620.03
4040002 HC0 700037 70078 7014008 202297 4000135 10 10.01 FRINGE BENEFITS - CURR PERSONNEL 0.00 3,469.97 3,469.97
0.00
0.00
TOTAL 0.00 (0.00) 26,090.00 26,090.00
DESCRIPTION:
mod to establish funds in salary and fringe accounts for 21CHMO award
FDP Subaward Amendment
_Amendment No_[01 Subaward No [27-515
Pass-Through Entity (PTE) Subrecipient
gt EntityN [DC Department of
‘spasubs@gwu.edu ] Contact Email [leah.varga@de gov
AraMaria Del RioGonzalez Principal nvesigator [LeahVarga
_____________]
Project Title[niesAdeline APen coachngintervenbon to Promale Chenaprophyians for HVPrevenuon arong Lat Tronagende” Woman heWashisgion
DCMapai Area
/PTE/Prime Award No [ 1 U01PS005218-03-00 ‘Awarding Agency [Department OF Health
AndHuman Services
CumulativeBudgetPeriod(s) |_| Amount Funded This Action _| Total Amount of Funds Obligated to Date
Start Date: | 06/01/2021| End Date: |05/31/2024|||$ 26,177.00 $ 54,416.00
|Subrecpint Cost Share[J]subject to FFATA [Bl]| Subreciient UEI wana[ XUYTNGMMLKES
Amendment{s) to Original Terms and Conditions
‘This Amendment revises the above-referenced Subaward Agreement as follows’
[i] Additional Budget Periods
‘Addtonal budgetperiod[osmvama——] . [Bwaraze
isherebyadded to his Subaward
[vecostextension
[H)additional Funding
‘Additional funding in the amount of [$ 28,177.00 _ ]is hereby obligated to this Subaward.
[Cocotiigation
Caryoverts[Automatic
—] Caryoveris alowed across al budget pero.
[carryover Authorized
[i] Detailed BudgetiScopeof Work/Notice of Award Attachad ist» tans Ne Rete Sumner mabe Oe
(A Scope of Work & Budk i incorporated by attachment to this Amendment.
i] other (See Bolow)
Invoicing shall be completed in accordance with ATTACHMENT 8-1 instructions. See Attachment 5A-2 for SOW and §B-2 for
Budget and Budget Justification
Federal Funds Obligated Yr.1 (06/01/2021-05/31/2022)......$26,238,00
Federal Funds Obligated ¥r.2 (06/01/2022-05/31/2023).......$15,429.00
Federal Funds Obligated Yr.3 (06/01/2023-05/31/2024)...... $12,748.00
Total Amount of Federal Funds Obligated to Date. $54,416.00
Forclarity:ellamountsstatedin this amendment are in United States Dollars 7
All other terms and conditionsof this Subaward Agreement remain in full force and effect.
te
By an Authorized Officialof PTE: ByanAut Official of Sytigipient:
Date
Nasri Kheshand ___[osinpa - Bay
Name[Nein shang ane[ Avene Boneh,
MSPHLFan
i aera———]| bee
GW.PTA# 41818-1-CCLS91457F
ATTACHMENT SA-2
SOW-District of Columbia Department of Health
The proposed project includes establishment of a consortium agreement between The George
Washington University and the HIV/AIDS, Hepatitis, STD and TB Administration (HAHSTA) of
the DC Department of Health. Under this arrangement, HAHSTA will perform the following
tasks:
1. Work collaboratively with investigators at The George Washington University (Applicant
Institute Pl: Ana Maria del Rio-Gonzélez, Ph.D.) to accomplish the proposed project's aims to:
(a) develop a peer-coaching intervention to promote PrEP and PEP uptake and adherence
among LTW; and (b) examine feasibility, acceptability and preliminary efficacy of the peer-
coaching intervention.
2. Participate in all meetings of the Community-Based Participatory Research (CBPR) team,
held in-person or via online video conference should the provisions for social distancing are still
in place. These meetings will mostly focus on the developmentofthe intervention (Months 3-5,
Year 1), the assessment of progress and identification of potential solutions if needed (Month
10, Year 1; Months 3 and 9, Year 2) and the interpretationoffindings and planning of
dissemination activities (Months 6-9, Year 3). Staff member (Cecilia Llanos) will represent
HAHSTA in the CBPR team.
3. Serve as Co-Investigators on the proposed project to recruit participants; collaborate on the
design of data collection instruments, the analysis and interpretation of qualitative and
quantitative data, and the study's dissemination plan, including the preparation and presentation
of findings through community events, national and/or international professional conferences
and peer-reviewed publications.
Work Involving Human or Vertebrate Animals (Select Applicable Options)
[1Nottmen vesicle
[i] Human subjects
ire
1 vertebrate Animals
‘ThePTErequiesvrifcaion of IRB andorIACUCapproval besontto the| Prncpalinvestigator ]0srequiredabove:
Subrecpient agrees that any non-exempt human andlor vertebrate animal research protocol conducted under th Subaward shall be reviewed and
approved by the appropriate InstutonalReviw Board (IRB) andor its Insitutonal Animal Care and Use Commitee (VACUC), as appicable and that
‘it will maintain current and duly approved research protocols for all periods of the Subaward involving human and/or vertebrate animal research.
‘Subrecipient certifies that the appropriate IRB andlor IACUC are in full compliance with applicable state and federal laws and regulations. The
Subrecipent cortifes that any submited IRB IACUC approval represents aval, approved protocol thats ently consistent wih the Projet
associated wit this Subaward. n no event shall Subrecent invoice orbe reimbursed fr ay human or vertebrate animals elated expenses incured
ina period where any applicable IRB /JACUC approvals not propery in pace
Human Subjects Data (Select One)
This section left intentionally blank
NIH Terms and Conditions
‘The Clinical Trial Indicator in Section IVofthe PTE’s NOA is stated as:
Multiple Pis (MPI)
This subaward is subject to an MPI Leadership Plan. Both parties will follow the finalized MP! Leadership Plan.
[The MPI planisattached as part of Attachment 6.
Certificate of Confidentiality:
‘The Parties agree that this research funded in whole or in part by the National Institutesof Health ("NIH’), is subject to NIH Policy
NOT-OD-17-109 (the *Policy’) and therefore is deemed under the Policy to be issued a Certificateof Confidentiality (“Certificate”)
should the conditions outlined within the Policy apply. Accordingly, the subrecipients who collect or receive identifiable, sensitive
information are is required to adhere to the Policy and protect the privacy of individuals who are subjects of such research in
accordance with the Policy and subsection 301(d)ofthe Public Health Service Act (the “PHS Act’).
Additional Terms
Invoicing shall be completed in accordance with ATTACHMENT8 instructions.
‘THE GEORGE WASHINGTON UNIVERSITY
Information. heet on thePreparation
ofSubrecipier
nvoige Instructions (Sample Attached)
(1) Subrecipient to address Invoice to GWs complete name and address as indicated in the Subaward Agreement.
(2) Subrecipient
to show complete Subaward Agreement number and latest modification and prime Grant/Cooperative
Agreemen¥/Contract mumber under which the Subaward Agreement is written,
3) Subaward Agreement period (Beginning date & Expiration date).
(4) Subaward Agreement cumulative funded amount,
(5) Date Invoice prepared.
(6) tnvoice Number in numerical order. The final invoice should be clearly marked Final Invoice.
(1) Expense categories:Listallexpeusesandincludedetailforthefollowingcategories:
(@) Salaries
(b) Fringe Benefits
(e) Equipment
(@) Consultants
(©) Travel
(Supplies
(8)Patient Care
(i) Sub-awards
IndirectCost
(8) Billing Period-date(s) or period(s)forwhich expenses are claimed; for example,
“Rebruary 1 to February 28, 2022”
Expenses for the billing month/period to be listed here.
(9) Cumulative costs claimed including those claimed under Item 8.
(10) Indicate the Cumulative Payments Received asofthe dateof the invoice (item#5),
(11) Certification by appropriate Subrecipient financial officer and address where check is to be
General:
(1) The Subrecipient may invoice on its own letterhead or on any other form desired as long as all the items
previously indicated are included.
(2) Invoices preferred methodofreceipt is via email to the Principal Investigator's and/or to the contact person
specified in the agreement.
(3) When electronic submission is not possible, an original and2 copies ofthe invoice shouldbe mailed to the
Principal Investigator and or contact specified in the agreement.
(4) Subrecipicnt’s latest negotiated Indirect Costs Rate Agreement mustbeon file as per 2.CFR 200,331 at The
George Washington University in order to process invoices and verify indirect rate applicable to invoices
received
(3) Invoices shall be submitted no more frequently than monthly, nor less frequently than quarterly and shall be
submitted within 60 daysofthe endofthe period coveredbythe invoice.
(©) Invoices must include any Program Income generated during the period for which the invoice represents and
include any cumulative balances.
(7) Invoices must include any Cost Sharing committed and expensed during the period for which the invoice
represents and include any cumulative balances.
(8) Certification to accompany each invoice: “By signing this report I certify to the bestofmy knowledge and
belief that the report is true, complete, and accurate, and the expenditures, disbursements andcash
receipts arefor thepurposes andobjectives setforth in the terms andconditions of the Federal award. 1
‘am awarethatany false,fictitious, orfraudulent information, orthe omissionof any materialfact, may
subject me to criminal, civilor administrativepenaltiesforfraud,false statements,false claims or
otherwise. (U.S. Code Title 18, section 1001 and Title 31, Sections 3729-3730 and 3801-3812).”
TTACUMENT 8:1— SINGREQUIREMENTS
NVOICE SAMPLE
SUBRECIPIENT’SLETTERHEAD
(1) THE GEORGE WASHINGTON UNIVERSITY
(2) SubawardAgreement Number#89-S01
under Grant/Contract #
3) SubswardAgreementPeriod:01/01/2022-12/31/2022
(4) SubawardAgreement Amount: $161,785.00
(5) Date: March 6, 2022
(©) INVOICE #2
Billing Period Cumulative
Expenditure Categories(7) (8) 02/01/2022-02/28/2022 (9) Expenses
Salaries-Lisa Jones, Principal Investigator 20% effort (or 40 hours) $16,142.95 $32,285.89
Fringe Benefits @ 19%ofSalarie